Jushi Holdings Inc (JUSHF)
0.70
-0.02
(-2.79%)
USD |
OTCM |
May 17, 15:59
Jushi Holdings Enterprise Value: 321.99M for May 16, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 321.99M |
| May 15, 2024 | 319.27M |
| May 14, 2024 | 316.03M |
| May 13, 2024 | 310.40M |
| May 10, 2024 | 316.44M |
| May 09, 2024 | 314.10M |
| May 08, 2024 | 317.05M |
| May 07, 2024 | 310.17M |
| May 06, 2024 | 318.23M |
| May 03, 2024 | 323.26M |
| May 02, 2024 | 322.02M |
| May 01, 2024 | 322.18M |
| April 30, 2024 | 351.46M |
| April 29, 2024 | 310.16M |
| April 26, 2024 | 311.52M |
| April 25, 2024 | 305.25M |
| April 24, 2024 | 314.55M |
| April 23, 2024 | 313.37M |
| April 22, 2024 | 307.61M |
| April 19, 2024 | 305.44M |
| April 18, 2024 | 312.92M |
| April 17, 2024 | 318.32M |
| April 16, 2024 | 308.22M |
| April 15, 2024 | 312.05M |
| April 12, 2024 | 300.33M |
| Date | Value |
|---|---|
| April 11, 2024 | 316.89M |
| April 10, 2024 | 311.56M |
| April 09, 2024 | 316.24M |
| April 08, 2024 | 318.70M |
| April 05, 2024 | 321.87M |
| April 04, 2024 | 314.59M |
| April 03, 2024 | 331.01M |
| April 02, 2024 | 313.15M |
| April 01, 2024 | 315.04M |
| March 31, 2024 | 323.30M |
| March 28, 2024 | 328.06M |
| March 27, 2024 | 330.67M |
| March 26, 2024 | 328.57M |
| March 25, 2024 | 316.89M |
| March 22, 2024 | 328.68M |
| March 21, 2024 | 334.35M |
| March 20, 2024 | 321.94M |
| March 19, 2024 | 321.80M |
| March 18, 2024 | 332.03M |
| March 15, 2024 | 324.57M |
| March 14, 2024 | 306.35M |
| March 13, 2024 | 310.00M |
| March 12, 2024 | 303.12M |
| March 11, 2024 | 299.90M |
| March 08, 2024 | 307.05M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-23.85M
Minimum
Jun 28 2019
1.268B
Maximum
Feb 09 2021
424.31M
Average
328.50M
Median
Feb 21 2023
Enterprise Value Benchmarks
| Anika Therapeutics Inc | 309.50M |
| Spero Therapeutics Inc | 8.279M |
| scPharmaceuticals Inc | 154.90M |
| electroCore Inc | 36.24M |
| NovaBay Pharmaceuticals Inc | 5.209M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -18.36M |
| Revenue (Quarterly) | 65.46M |
| Total Expenses (Quarterly) | 61.34M |
| EPS Diluted (Quarterly) | -0.09 |
| Gross Profit Margin (Quarterly) | 49.39% |
| Profit Margin (Quarterly) | -28.04% |
| Earnings Yield | -51.43% |
| Operating Earnings Yield | 9.07% |
| Normalized Earnings Yield | -44.45 |